Learn More
Medchemexpress LLC Dasminapant | 1570231-89-8 | 99.7% | 1157.40 | C60H72N10O10S2 | 1MG

Supplier: Medchemexpress LLC HY1255931MG
Dasminapant (APG-1387) is a bivalent SMAC mimetic and inhibitor of apoptosis protein (IAP) antagonist provided for research use. It promotes degradation of cIAP-1 and XIAP, activates caspase-3, and induces apoptosis in preclinical cancer models, supporting studies in hepatocellular, ovarian, and nasopharyngeal carcinoma.
- Bivalent SMAC mimetic that antagonizes IAP family proteins.
- Promotes degradation of cIAP-1 and XIAP and triggers caspase activation.
- Used in preclinical studies of various solid tumors.
- High reported purity suitable for research applications.
- Available in small milligram pack sizes for experimental use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.